Instead of 'curling up in a corner,' Mylan CEO says, she used EpiPen to fight flawed pricing

Instead of 'curling up in a corner,' Mylan CEO says, she used EpiPen to fight flawed pricing

Source: 
Fierce Pharma
snippet: 

Why didn't Mylan CEO Heather Bresch back down when attacked about the company's repeated price increases on EpiPen? Two years later, Bresch is still blaming the "broken" U.S. pricing system for the huge spike in cost for the anaphylaxis rescue injection.